Survival outcomes in breast cancer patients with low estrogen/progesterone receptor expression
A Balduzzi, V Bagnardi, N Rotmensz… - Clinical breast …, 2014 - Elsevier
Introduction The prognostic value of low estrogen and progesterone receptors expression
(ER/PgR 1%-10%) in early breast cancer patients is still unclear. Patients and Methods We …
(ER/PgR 1%-10%) in early breast cancer patients is still unclear. Patients and Methods We …
Survival outcomes in breast cancer patients with low estrogen/progesterone receptor expression
A Balduzzi, V Bagnardi, N Rotmensz… - CLINICAL BREAST …, 2014 - ricerca.uniba.it
Introduction The prognostic value of low estrogen and progesterone receptors expression
(ER/PgR 1%-10%) in early breast cancer patients is still unclear. Patients and Methods We …
(ER/PgR 1%-10%) in early breast cancer patients is still unclear. Patients and Methods We …
Survival outcomes in breast cancer patients with low estrogen/progesterone receptor expression
A Balduzzi, V Bagnardi, N Rotmensz… - CLINICAL BREAST …, 2014 - boa.unimib.it
Introduction The prognostic value of low estrogen and progesterone receptors expression
(ER/PgR 1%-10%) in early breast cancer patients is still unclear. Patients and Methods We …
(ER/PgR 1%-10%) in early breast cancer patients is still unclear. Patients and Methods We …
Survival outcomes in breast cancer patients with low estrogen/progesterone receptor expression.
A Balduzzi, V Bagnardi, N Rotmensz… - Clinical Breast …, 2013 - europepmc.org
Results Group 1 (ER/PgR< 1%) included 1300 patients, and group 2 (ER/PgR 1%-10%) 124
patients. Median follow-up time was 74 months (range, 3-192 months). The 5-year disease …
patients. Median follow-up time was 74 months (range, 3-192 months). The 5-year disease …
Survival outcomes in breast cancer patients with low estrogen/progesterone receptor expression
A Balduzzi, V Bagnardi, N Rotmensz… - Clinical breast …, 2014 - pubmed.ncbi.nlm.nih.gov
Introduction The prognostic value of low estrogen and progesterone receptors expression
(ER/PgR 1%-10%) in early breast cancer patients is still unclear. Patients and methods We …
(ER/PgR 1%-10%) in early breast cancer patients is still unclear. Patients and methods We …
Survival outcomes in breast cancer patients with low estrogen/progesterone receptor expression
A Balduzzi, V Bagnardi, N Rotmensz… - CLINICAL BREAST …, 2014 - air.unimi.it
Introduction The prognostic value of low estrogen and progesterone receptors expression
(ER/PgR 1%-10%) in early breast cancer patients is still unclear. Patients and Methods We …
(ER/PgR 1%-10%) in early breast cancer patients is still unclear. Patients and Methods We …
Survival Outcomes in Breast Cancer Patients With Low Estrogen/Progesterone Receptor Expression
A Balduzzi, V Bagnardi, N Rotmensz… - Clinical Breast …, 2014 - clinical-breast-cancer.com
Introduction The prognostic value of low estrogen and progesterone receptors expression
(ER/PgR 1%-10%) in early breast cancer patients is still unclear. Patients and Methods We …
(ER/PgR 1%-10%) in early breast cancer patients is still unclear. Patients and Methods We …
Survival Outcomes in Breast Cancer Patients With Low Estrogen/Progesterone Receptor Expression
A Balduzzi, V Bagnardi, N Rotmensz… - Clinical Breast …, 2014 - infona.pl
The prognostic value of low estrogen and progesterone receptors expression (ER/PgR 1%-
10%) in early breast cancer patients is still unclear. We retrospectively analyzed 1424 …
10%) in early breast cancer patients is still unclear. We retrospectively analyzed 1424 …